Back
Corporate News
Anlon Healthcare to approve financials and consider director reappointment on August 11
06-Aug-2026, 10:36
Anlon Healthcare Limited will hold a board meeting on August 11, 2026, to approve the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and to consider the re-appointment of Mr. Punitkumar Rameshbhai Rasadia as a director. The board will also consider the issuance of equity shares on a preferential basis to shareholders of Apiqo Organics Private Limited and Bizotic Lifescience Private Limited, in lieu of the acquisition of their shares, and related party transactions with Apiqo Organics Private Limited, Bizotic Lifescience Private Limited, and Remember India Health Links Private Limited.
Anlon Healthcare Limited will hold a board meeting on August 11, 2026, to approve the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and to consider the re-appointment of Mr. Punitkumar Rameshbhai Rasadia as a director. The board will also consider the issuance of equity shares on a preferential basis to shareholders of Apiqo Organics Private Limited and Bizotic Lifescience Private Limited, in lieu of the acquisition of their shares, and related party transactions with Apiqo Organics Private Limited, Bizotic Lifescience Private Limited, and Remember India Health Links Private Limited.